Invention Grant
- Patent Title: Myopia control means
-
Application No.: US15416674Application Date: 2017-01-26
-
Publication No.: US10156737B2Publication Date: 2018-12-18
- Inventor: Aldo Abraham Martinez , Arthur Ho , Padmaja Rajagopal Sankaridurg , Percy Fabian Lazon , Brien Anthony Holden , Rick Payor , Gregor F. Schmid
- Applicant: Novartis AG , Brien Holden Vision Institute
- Applicant Address: CH Basel AU Sydney
- Assignee: Novartis AG,Brien Holden Vision Institute
- Current Assignee: Novartis AG,Brien Holden Vision Institute
- Current Assignee Address: CH Basel AU Sydney
- Agent Robert A. Ambrose
- Priority: AU2008901921 20080418
- Main IPC: G02C7/02
- IPC: G02C7/02 ; G02C7/06 ; G02C7/04 ; A61B3/00 ; G02C13/00

Abstract:
Sets, kits or stocks of anti-myopia lenses and methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than −6D central refractive error. For example, a kit or set of lenses (50, FIG. 15) can have multiple parts or sub-sets each with a compartmented container with lenses arranged according to increments of central corrective power. The lenses of the first part have four steps of peripheral power or defocus to provide therapeutic effect and, while the lenses of the second part also have four steps, the level of therapeutic effect is higher. Other examples of sets, kits and stocks, as well as examples of lenses themselves, are disclosed together with methods of use.
Public/Granted literature
- US20170146824A1 MYOPIA CONTROL MEANS Public/Granted day:2017-05-25
Information query